Reuters logo
BRIEF-Nuvectra files regulatory submission with FDA for Algovita MRI-conditional approval
June 21, 2017 / 11:16 AM / 6 months ago

BRIEF-Nuvectra files regulatory submission with FDA for Algovita MRI-conditional approval

June 21 (Reuters) - Nuvectra Corp

* Nuvectra files regulatory submission with fda for Algovita MRI-conditional approval

* Nuvectra -submission, pending regulatory approval from FDA, would position company to achieve MRI-conditional approval at or around year end 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below